Tissue-type plasminogen activator transgenic rats for evaluating inhibitors of the activated form of thrombin-activatable fibrinolysis inhibitor.

about

Tissue-type plasminogen activator transgenic rats for evaluating inhibitors of the activated form of thrombin-activatable fibrinolysis inhibitor.

Item

http://www.wikidata.org/entity/Q55333995

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Tissue-type plasminogen activa ...... atable fibrinolysis inhibitor.

@en

Tissue-type plasminogen activa ...... atable fibrinolysis inhibitor.

@nl

type

Item

label

Tissue-type plasminogen activa ...... atable fibrinolysis inhibitor.

@en

Tissue-type plasminogen activa ...... atable fibrinolysis inhibitor.

@nl

prefLabel

Tissue-type plasminogen activa ...... atable fibrinolysis inhibitor.

@en

Tissue-type plasminogen activa ...... atable fibrinolysis inhibitor.

@nl

P1476

Tissue-type plasminogen activa ...... atable fibrinolysis inhibitor.

@en

P2093

Kengo Noguchi

http://www.w3.org/2001/XMLSchema#string

Kyoji Yamaguchi

http://www.w3.org/2001/XMLSchema#string

Yoshiyuki Morishima

http://www.w3.org/2001/XMLSchema#string

Yusuke Ito

http://www.w3.org/2001/XMLSchema#string

P2860

Heart Disease and Stroke Statistics--2015 Update: A Report From the American Heart Association

Heart Disease and Stroke Statistics--2013 Update: A Report From the American Heart Association

Thrombus formation in vivo.

Review of the cost of venous thromboembolism

Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.

A Novel Model of Intravital Platelet Imaging Using CD41-ZsGreen1 Transgenic Rats

A novel inhibitor of activated thrombin activatable fibrinolysis inhibitor (TAFIa) - part II: enhancement of both exogenous and endogenous fibrinolysis in animal models of thrombosis.

An inhibitor of activated thrombin-activatable fibrinolysis inhibitor potentiates tissue-type plasminogen activator-induced thrombolysis in a rabbit jugular vein thrombolysis model.

Purification and properties of a carboxypeptidase inhibitor from potatoes.

Thrombin-activatable fibrinolysis inhibitor deficiency attenuates bleomycin-induced lung fibrosis.

P304

314-321

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/MBC.0000000000000723

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29538006

http://www.w3.org/2001/XMLSchema#string

P932

5943070

http://www.w3.org/2001/XMLSchema#string